Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos Neglected Tropical Diseases|February 27, 2016
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and EfficacyJason W Bennett, Anjali Yadava, Donna Tosh, et al.
Vaccines|May 25, 2024
Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical TrialJulie A Ake, Kristopher Paolino, Jack N Hutter, et al.
Plos One|July 7, 2015
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve AdultsChristian F Ockenhouse, Jason Regules, Donna Tosh, et al.
Eclinicalmedicine|March 8, 2021
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trialChristine Johnston, Elizabeth R Brown, Jenell Stewart, et al.
Annals of Internal Medicine|December 7, 2020
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized TrialRuanne V Barnabas, Elizabeth R Brown, Anna Bershteyn, et al.
The Lancet. Infectious Diseases|July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trialKayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
Science Translational Medicine|April 2, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filovirusesThembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, et al.
JAMA|August 13, 2025
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical TrialNicholas A Turner, Toshimitsu Hamasaki, Sarah B Doernberg, et al.
Pageof 2